T Scientific Statistics

Total Valuation

T Scientific has a market cap or net worth of KRW 56.64 billion. The enterprise value is 56.50 billion.

Market Cap	56.64B
Enterprise Value	56.50B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

T Scientific has 71.25 million shares outstanding. The number of shares has increased by 12.76% in one year.

Current Share Class	n/a
Shares Outstanding	71.25M
Shares Change (YoY)	+12.76%
Shares Change (QoQ)	-5.03%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	4.01%
Float	47.76M

Valuation Ratios

The trailing PE ratio is 24.84.

PE Ratio	24.84
Forward PE	n/a
PS Ratio	1.28
PB Ratio	0.40
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	25.41
EV / Sales	1.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.26

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.05.

Current Ratio	1.05
Quick Ratio	0.90
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.51
Interest Coverage	-12.28

Financial Efficiency

Return on equity (ROE) is 1.69% and return on invested capital (ROIC) is -4.57%.

Return on Equity (ROE)	1.69%
Return on Assets (ROA)	-3.94%
Return on Invested Capital (ROIC)	-4.57%
Return on Capital Employed (ROCE)	-7.50%
Revenue Per Employee	232.52M
Profits Per Employee	12.02M
Employee Count	185
Asset Turnover	0.26
Inventory Turnover	136.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.16% in the last 52 weeks. The beta is 0.51, so T Scientific's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-44.16%
50-Day Moving Average	947.30
200-Day Moving Average	1,036.78
Relative Strength Index (RSI)	41.98
Average Volume (20 Days)	177,712

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, T Scientific had revenue of KRW 43.02 billion and earned 2.22 billion in profits. Earnings per share was 32.00.

Revenue	43.02B
Gross Profit	9.90B
Operating Income	-10.63B
Pretax Income	1.31B
Net Income	2.22B
EBITDA	-9.28B
EBIT	-10.63B
Earnings Per Share (EPS)	32.00

Full Income Statement

Balance Sheet

The company has 6.96 billion in cash and 6.73 billion in debt, giving a net cash position of 227.60 million or 3.19 per share.

Cash & Cash Equivalents	6.96B
Total Debt	6.73B
Net Cash	227.60M
Net Cash Per Share	3.19
Equity (Book Value)	140.40B
Book Value Per Share	1,969.42
Working Capital	1.00B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -13.16 billion and capital expenditures -96.07 million, giving a free cash flow of -13.26 billion.

Operating Cash Flow	-13.16B
Capital Expenditures	-96.07M
Free Cash Flow	-13.26B
FCF Per Share	-186.10

Full Cash Flow Statement

Margins

Gross margin is 23.02%, with operating and profit margins of -24.71% and 5.17%.

Gross Margin	23.02%
Operating Margin	-24.71%
Pretax Margin	3.04%
Profit Margin	5.17%
EBITDA Margin	-21.58%
EBIT Margin	-24.71%
FCF Margin	n/a

Dividends & Yields

T Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.76%
Shareholder Yield	-12.76%
Earnings Yield	3.93%
FCF Yield	-23.41%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

T Scientific has an Altman Z-Score of 1.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.71
Piotroski F-Score	n/a